Petros Pharmaceuticals Inc.
13F holders, Q1 2025 (March 31)15holders +6
6new positions
0sold out
$0.07avg. 13F price*
At the end of Q1 2025, 15 institutions reported holding Petros Pharmaceuticals Inc. in their 13F filings, up 6 from Q4 2024. 6 opened new positions and 0 sold out. The largest holders were Jane Street Group, LLC ($39K), HRT Financial LP ($9K) and UBS Group AG ($8K).
- Company
- Petros Pharmaceuticals Inc.
- CUSIP
- 71678J209
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $58K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 1,032,455 shares bought, net +1,032,455 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Jane Street Group, LLC | 0.00% | New | 563,594 | $39K |
| HRT Financial LP | 0.00% | New | 137,515 | $9K |
| UBS Group AG | 0.00% | Add +816.5% | 119,072 | $8K |
| Geode Capital Management, LLC | 0.00% | Add +199.0% | 108,180 | $7K |
| XTX Topco Ltd | 0.00% | New | 90,905 | $6K |
| Two Sigma Securities, LLC | 0.00% | New | 61,345 | $4K |
| Vanguard Group Inc. | 0.00% | No change | 31,811 | $2K |
| BlackRock, Inc. | 0.00% | No change | 16,128 | $1K |
| Morgan Stanley | 0.00% | Add +3605.3% | 704 | $48 |
| SBI Securities Co., Ltd. | 0.00% | New | 320 | $22 |
| National Bank of Canada | 0.00% | No change | 200 | $14 |
| Osaic Holdings, Inc. | 0.00% | No change | 200 | $14 |
| Bank of America Corp. | 0.00% | Add +5.3% | 79 | $5 |
| Group One Trading LLC | 0.00% | No change | 79 | $5 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 11 | $1 |
"% of holder's portfolio" is PETROS PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Petros Pharmaceuticals Inc. the manager owns.